We provide you with 20 years of free, institutional-grade data for FBRX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of FBRX. Explore the full financial landscape of FBRX stock.
| Reported Date | CIK | Ticker | Type |
|---|
Forte Biosciences, Inc.(NASDAQ:FBRX) 
Forte Biosciences Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing a live biotherapeutic FB-401 that has completed Phase 1/2a clinical trial to treat inflammatory skin diseases for pediatric atopic dermatitis patients. The company was incorporated in...
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about FBRX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.